Search results
Results from the WOW.Com Content Network
In 2018, HHS proposed a new rule that would reduce reimbursement rates for only 340B hospitals, but did not conduct a survey of hospital acquisition costs. In its final rule, HHS retained the approximately 106 percent reimbursement rate for non-340B hospitals, and established a 77.5 percent reimbursement rate for 340B hospitals.
Administrative costs. About 25% of U.S. healthcare costs relate to administrative costs (e.g., billing and payment, as opposed to direct provision of services, supplies and medicine) versus 10-15% in other countries. For example, Duke University Hospital had 900 hospital beds but 1,300 billing clerks.
In April 2020, Grimm released a report which surveyed the state of hospitals in late March during the COVID-19 pandemic in the United States. The hospitals reported "severe shortages of testing supplies", "frequently waiting 7 days or longer for test results", which extended the length of patient stays and strained resources, and "widespread ...
“The Safety and Health of all Americans is the most important role of any Administration, and HHS will play a big role in helping ensure that everybody will be protected from harmful chemicals ...
Daniel R. Levinson was the longest-serving HHS Inspector General from 2004 to 2019. The OIG consists of the following components: Office of Audit Services (OAS). OAS conducts audits that assess HHS programs and operations and examine the performance of HHS programs and grantees. In FY 2020, OIG produced 178 audits.
The Health Resources and Services Administration (HRSA) is an agency of the U.S. Department of Health and Human Services located in North Bethesda, Maryland.It is the primary federal agency for improving access to health care services for people who are uninsured, isolated or medically vulnerable.
President-elect Donald Trump’s nomination of Robert F. Kennedy Jr. as head of the Department of Health and Human Services (HHS) has raised a lot of questions about the future of healthcare in ...
Dr. Scott Gottlieb, the former commissioner of the Food and Drug Administration, on Friday raised concerns about Robert F. Kennedy Jr.’s agenda for the Department of Health and Human Services.